DOMiNO Ventures and UzVC Launch SGP Life Sciences Acceleration Program for Central Asian Biotech, Healthtech and Pharmatech Startups

SGP Life Sciences

DOMiNO Ventures and UzVC are launching the SGP Life Sciences Acceleration Program for startups from Central Asia in the Biotech, Healthtech and Pharmatech sectors.

The two-month program will bring selected startups together with global mentors, industry experts, venture capital firms, and international investors, combining hands-on acceleration support with direct access to international networks and capital.
 

 

The SGP Life Sciences Acceleration Program is designed for startups with established products or solutions in Biotech, Healthtech, and Pharmatech that are ready to grow their business, prepare for fundraising, and explore international markets. Through tailored support and hands-on mentorship, selected teams will work on key areas such as business strategy, fundraising, and market expansion.
 

 

Throughout the two-month program, teams will work with global mentors, industry experts, and experienced investors, gaining practical insights and building relationships relevant to their sector and growth plans. The program will also create opportunities for direct conversations with international venture capital firms and potential investors.
 

 

Starting in October 2026, the program will conclude with a two-day physical Bootcamp in Uzbekistan, followed by a Demo Day. Startups will meet investors, corporates, founders, and ecosystem leaders, and present to global VCs to explore funding, partnerships, and international expansion opportunities.
 

 

Applications are open until September 18, 2026. Startups can apply through the application form here: Apply by link
 

 

UzVC Comments on the SGP Life Sciences Acceleration Program
 

Dilshod Khashimov, CEO of UzVC:
“Uzbekistan’s ongoing reforms in science, innovation, and healthcare are creating a strong foundation for the growth of Life Sciences. SGP Life Sciences is designed to build on this momentum by helping founders bridge the gap between scientific innovation and commercialization, turning promising ideas into scalable businesses with real-world impact.”
 

DOMiNO Ventures Comments on the SGP Life Sciences Acceleration Program
 

Yagiz Karadeniz, Managing Partner of DOMiNO Ventures:
“Central Asia has a growing base of Life Sciences founders with the potential to build globally competitive companies. Through SGP Life Sciences, we aim to help them become investment-ready, build the right international connections, and move toward funding, partnerships, and global expansion.”